Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
0(0%)
Results Posted
140%(7 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_3
3
33%
Ph phase_2
4
44%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
4(50.0%)
Phase 3Large-scale testing
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Completed5
Terminated2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 24 (50.0%)
Phase 33 (37.5%)

Trials by Status

unknown111%
completed556%
terminated222%
withdrawn111%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

NCT01737762
completedphase_1

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds

NCT01190865
completedphase_2

Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients

NCT01359735
completedphase_2

Dose Finding Study of HP802-247 in Venous Leg Ulcers

NCT00852995
terminatedphase_3

Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers

NCT01853384
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT01737762Phase 3

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

Completed
NCT01190865Phase 1

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds

Completed
NCT01359735Phase 2

Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients

Completed
NCT00852995Phase 2

Dose Finding Study of HP802-247 in Venous Leg Ulcers

Completed
NCT01853384Phase 3

Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers

Terminated
NCT02154087Phase 2

A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers

Terminated
NCT01656889Phase 3

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Completed
NCT01658618

Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer

Unknown
NCT01528306Phase 2

A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa

Withdrawn

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9